Eden Research Plc (LON: EDEN) has announced that its commercial partner, Eastman Chemical Company, has received full authorisation for Eden's nematicide formulation, marketed as Cedrozâ¢ by Eastman, in Mexico.
- The company has reported that with this authorisation access has now been gained into the all-important US agricultural import market. It is first for the companyâs developed products in Mexico, giving it a foothold into the Americas.
- Cedroz an innovative and natural solution, offers growers huge benefits by offering high levels of efficacy against nematodes.
- On 19th December 2019, at the time of writing, GMT 08:03 AM, EDEN shares were trading at GBX 8.75, up by 0.95 points or 12.18% against the previous day closing price.